Wikidata

(Q54447239)

English

Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab.

scientific article published on 26 February 2013

In more languages

Statements

title
Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23444220
retrieved
29 May 2018
reference URL
http://europepmc.org/abstract/MED/23444220
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q54447239&oldid=1650936024"